Golden
JDRF T1D Fund

JDRF T1D Fund

JDRF T1D Fund is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities.

JDRF T1D Fund is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities. The firm was launched in 2016 and is solely focused on T1D investments. The firm looks to provide equity investments in companies developing T1D products. Their portfolio consists of therapeutics, devices, vaccines, and diagnostics.

The firm has invested in fifteen companies, and holds $70 million in assets, and has helped raised over $200 million for their portfolio.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

SQZ Biotech is a biotechnology company using their cell engineering platform for developing cell therapies for treating immune disorders.

Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.

A biotechnology company developing therapies and personalized diagnostics for celiac disease

Veralox Therapeutics is a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc.

Biolinq, Inc. is a San Diego-based company founded by Joshua Windmiller.

Diasome Pharmaceuticals is a Cleveland-based company.

Pandion Therapeutics is a Cambridge, Massachusetts-based company.

10 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References